Medical Xpress: Innovative Pancreatic Cancer Treatment Expands Survival Prospects

This article, published by Medical Xpress on November 10, 2023, highlights a breakthrough in pancreatic cancer treatment. Researchers from VCU Massey Comprehensive Cancer Center and VCU Institute of Molecular Medicine developed a treatment using polyinosine-polycytidylic acid (pIC) that, when delivered into pancreatic tumor cells, effectively suppresses tumor growth and promotes cancer cell death. This innovative approach, showing promise in preclinical studies, could significantly improve survival rates for pancreatic ductal adenocarcinoma (PDAC) patients. The treatment, when combined with existing cancer medications, has shown enhanced effectiveness and safety in animal models, representing a significant advancement in pancreatic cancer therapy.

Read the full article on Medical Xpress for more detailed information.